Cargando…
CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism
Human arylamine N-acetyltransferase 1 (NAT1), present in all tissues, is classically described as a phase-II xenobiotic metabolizing enzyme but can also catalyze the hydrolysis of acetyl-Coenzyme A (acetyl-CoA) in the absence of an arylamine substrate using folate as a cofactor. NAT1 activity varies...
Autores principales: | Carlisle, Samantha M., Trainor, Patrick J., Hong, Kyung U., Doll, Mark A., Hein, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299936/ https://www.ncbi.nlm.nih.gov/pubmed/32555504 http://dx.doi.org/10.1038/s41598-020-66863-4 |
Ejemplares similares
-
Human Arylamine N-Acetyltransferase 1 (NAT1) Knockout in MDA-MB-231 Breast Cancer Cell Lines Leads to Transcription of NAT2
por: Carlisle, Samantha M., et al.
Publicado: (2022) -
Dataset for proteomic analysis of arylamine N-acetyltransferase 1 knockout MDA-MB-231 breast cancer cells
por: Hong, Kyung U., et al.
Publicado: (2022) -
Effect arylamine N-acetyltransferase 1 on morphology, adhesion, migration, and invasion of MDA-MB-231 cells: role of matrix metalloproteinases and integrin αV
por: Li, Pengcheng, et al.
Publicado: (2020) -
BSA-PEI Nanoparticle Mediated Efficient Delivery of CRISPR/Cas9 into MDA-MB-231 Cells
por: Rahimi, Hossein, et al.
Publicado: (2022) -
Arylamine N-Acetyltransferase 1 Activity is Regulated by the Protein Acetylation Status
por: Salazar-González, Raúl A., et al.
Publicado: (2022)